GnRH激动剂触发排卵后获卵率低和卵母细胞未成熟的危险因素
该双中心回顾性队列研究纳入2015至2021年1747例18-43岁接受控制性卵巢过度刺激并以GnRHa(曲普瑞林0.2 mg)触发排卵行ICSI或卵母细胞冷冻的患者,分析获卵率(ORR)低和卵母细胞成熟率(OMR)低的危险因素。多因素分析显示初始窦卵泡数和触发后12小时LH水平与低ORR负相关,BMI和AMH水平与OMR<75%负相关,抗促性腺激素预处理降低OMR<75%风险。
要点
- 初始窦卵泡数和触发后12小时LH水平越低,获卵率低于第10百分位的风险越高。
- BMI和AMH水平越高,卵母细胞成熟率<75%的风险越高。
- 抗促性腺激素预处理较未预处理降低卵母细胞成熟率<75%的风险。
核心结论
- 较低的卵巢储备和GnRHa触发后LH水平是获卵率低的危险因素,较高的BMI和AMH水平是卵母细胞成熟率低的危险因素。
研究设计与样本
- 双中心回顾性队列研究,纳入2015至2021年1747例18-43岁接受控制性卵巢过度刺激并以GnRHa(曲普雷林0.2 mg)单独触发排卵行ICSI或卵母细胞冷冻的患者。
主要发现
- 多因素分析中,初始窦卵泡数与获卵率低于第10百分位负相关(OR:0.61 [95% CI:0.42-0.88];P=0.008)。
- 触发后12小时LH水平与获卵率低于第10百分位负相关(OR:0.86 [95% CI:0.76-0.97];P=0.02),二者呈非线性关系,但未找到LH阈值。
- 25.3%的患者卵母细胞成熟率<75%。
- 多因素分析中,BMI与卵母细胞成熟率<75%负相关(OR:4.34 [95% CI:1.96-9.6];P<0.001)。
- AMH水平与卵母细胞成熟率<75%负相关(OR:1.22 [95% CI:1.03-1.12];P=0.015)。
临床怎么用
- 作者认为,临床实践中为避免获卵率低,对于BMI较高和/或卵巢储备低的患者不应考虑单独使用GnRHa触发,需权衡卵巢过度刺激综合征风险。
- 作者指出,若触发后12小时LH水平低, practitioners must be aware of the risk of poor ORR, and hCG retriggering could be considered.
局限性
- 研究受回顾性设计限制。
- 研究排除了接受hCG再次触发排卵的患者,但仅6个周期发生此情况。
- 未能收集预处理持续时间和洗脱期持续时间的信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What are the potential risk factors for poor oocyte recuperation rate (ORR) and oocyte immaturity after GnRH agonist (GnRHa) ovulation triggering? SUMMARY ANSWER: Lower ovarian reserve and LH levels after GnRHa triggering are risk factors of poor ORR. Higher BMI and anti-Müllerian hormone (AMH) levels are risk factors of poor oocyte maturation rate (OMR). WHAT IS KNOWN ALREADY: The use of GnRHa to trigger ovulation is increasing. However, some patients may have a suboptimal response after GnRHa triggering. This suboptimal response can refer to any negative endpoint, such as suboptimal oocyte recovery, oocyte immaturity, or empty follicle syndrome. For some authors, a suboptimal response to GnRHa triggering refers to a suboptimal LH and/or progesterone level following triggering. Several studies have investigated a combination of demographic, clinical, and endocrine characteristics at different stages of the treatment process that may affect the efficacy of the GnRHa trigger and thus be involved in a poor endocrine response or efficiency but no consensus exists. STUDY DESIGN, SIZE, DURATION: Bicentric retrospective cohort study between 2015 and 2021 (N = 1747). PARTICIPANTS/MATERIALS, SETTING, METHODS: All patients aged 18-43 years who underwent controlled ovarian hyperstimulation and ovulation triggering by GnRHa alone (triptorelin 0.2 mg) for ICSI or oocyte cryopreservation were included. The ORR was defined as the ratio of the total number of retrieved oocytes to the number of follicles >12 mm on the day of triggering. The OMR was defined as the ratio of the number of mature oocytes to the number of retrieved oocytes. A logistic regression model with a backward selection method was used for the analysis of risk factors. Odds ratios (OR) are displayed with their two-sided 95% confidence interval. MAIN RESULTS AND THE ROLE OF CHANCE: In the multivariate analysis, initial antral follicular count and LH level 12-h post-triggering were negatively associated with poor ORR (i.e. below the 10th percentile) (OR: 0.61 [95% CI: 0.42-0.88]; P = 0.008 and OR: 0.86 [95% CI: 0.76-0.97]; P = 0.02, respectively). A nonlinear relationship was found between LH level 12-h post-triggering and poor ORR, but no LH threshold was found. A total of 25.3% of patients suffered from oocyte immaturity (i.e. OMR < 75%). In the multivariate analysis, BMI and AMH levels were negatively associated with an OMR < 75% (OR: 4.34 [95% CI: 1.96-9.6]; P < 0.001 and OR: 1.22 [95% CI: 1.03-1.12]; P = 0.015, respectively). Antigonadotrophic pretreatment decreased the risk of OMR < 75% compared to no pretreatment (OR: 0.72 [95% CI: 0.57-0.91]; P = 0.02). LIMITATIONS, REASONS FOR CAUTION: Our study is limited by its retrospective design and by the exclusion of patients who had hCG retriggers. However, this occurred in only six cycles. We were also not able to collect information on the duration of pretreatment and the duration of wash out period. WIDER IMPLICATIONS OF THE FINDINGS: In clinical practice, to avoid poor ORR, GnRHa trigger alone should not be considered in patients with higher BMI and/or low ovarian reserve, balanced by the risk of ovarian hyperstimulation syndrome. In the case of a low 12-h post-triggering LH level, practicians must be aware of the risk of poor ORR, and hCG retriggering could be considered. STUDY FUNDING/COMPETING INTEREST(S): None. TRIAL REGISTRATION NUMBER: N/A.
引用
- Gambini S, Sonigo C, Robin G, et al. Risk factors for poor oocyte yield and oocyte immaturity after GnRH agonist triggering. Hum Reprod. 2024. PMID: 38452353. doi:10.1093/humrep/deae041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。